Showing results (841-850 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|October 20, 2022
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative ReviewMatthew G Krebs, Umberto Malapelle, Fabrice André, et al.
JAMA Oncology|October 24, 2022
Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration FacilitiesAlex K Bryant, Kyung Min Lee, Patrick R Alba, et al.
JAMA Oncology|September 29, 2022
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical TrialRobert Olson, Will Jiang, Mitchell Liu, et al.
JAMA Oncology|October 6, 2022
Pooled Analysis of Meningioma Risk Following Treatment for Childhood CancerDiana R Withrow, Harald Anderson, Gregory T Armstrong, et al.
JAMA Oncology|February 25, 2021
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic VariantsYun-Hee Choi, Mary Beth Terry, Mary B Daly, et al.
JAMA Oncology|March 11, 2021
Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic CancerMarsha Reyngold, Eileen M O'Reilly, Anna M Varghese, et al.
JAMA Oncology|March 11, 2021
Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical TrialCarlo Greco, Oriol Pares, Nuno Pimentel, et al.
JAMA Oncology|March 25, 2021
Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected MelanomaJ Randall Patrinely, Rebecca Johnson, Aleigha R Lawless, et al.
JAMA Oncology|January 6, 2022
Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial, Michelle Ghert, Patricia Schneider, et al.
JAMA Oncology|January 6, 2022
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration DatabaseMitchell S Anscher, Shaily Arora, Chana Weinstock, et al.
Pageof 161